Mark McClellan, Duke-Margolis Center for Health Policy

Duke to host pri­vate meet­ing with pay­ers and bio­phar­ma on how to pay for Alzheimer's drugs

How is the US go­ing to re­strict the use of Bio­gen’s new Alzheimer’s drug so Medicare doesn’t go bank­rupt be­fore the end of the decade …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.